Guardant Health
GH
168.33
-2.36
-1.38%
Guardant Health
US · GH
#820 by market cap
Listed 2018
168.33
-2.36
-1.38%
Live - 5344 symbols - heartbeat 271s ago
· 2026-10-08 06:41
Pre-market
168.33
0.00%
After-hours
168.33
0.00%
Overnight
167.98
-0.21%
- Market cap
- 22.59B
- P/E (TTM)i
- -47.96
- P/Bi
- -101.34
- EPSi
- -3.32
- Div yieldi
- 0.00%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on GH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.80, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +32.88% YoY
Margins
- Gross margin
- 64.46%
- Operating margin
- -44.53%
- Net margin
- -42.39%
Key ratios & quality
- Enterprise valuei
- 22.92B
- Altman Z-Scorei
- 4.80
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 90.64M | 214.38M | 286.73M | 373.65M | 449.54M | 563.95M | 739.02M | 982.02M |
| Gross profit | 47.43M | 143.66M | 194.20M | 250.74M | 293.21M | 336.90M | 449.22M | 633.01M |
| Selling & admin expenses | 89.66M | 139.73M | 299.28M | 398.52M | 463.78M | 451.03M | 545.06M | 706.07M |
| Research & development | 50.71M | 86.29M | 149.86M | 263.22M | 373.81M | 367.19M | 347.75M | 364.19M |
| Operating profit | -92.94M | -82.37M | -254.95M | -411.00M | -544.38M | -564.73M | -443.59M | -437.25M |
| Pretax profit | -84.23M | -69.72M | -245.90M | -384.47M | -653.45M | -478.76M | -435.09M | -417.54M |
| Tax | 38.00K | -1.87M | 379.00K | 300.00K | 1.14M | 685.00K | 1.28M | -1.26M |
| Net profit | -84.26M | -67.85M | -246.28M | -384.77M | -654.59M | -479.45M | -436.37M | -416.28M |
| Basic EPS | -3 | -1 | -3 | -4 | -6 | -4 | -4 | -3 |
| Diluted EPS | -2.80 | -0.84 | -2.60 | -4.00 | -6.41 | -4.28 | -3.56 | -3.32 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 203.47M | 232.09M | 265.20M | 281.27M | 301.67M | 334.98M |
| Gross profit | 128.75M | 150.88M | 171.61M | 181.77M | 196.75M | 219.03M |
| Selling & admin expenses | 151.27M | 169.85M | 180.64M | 204.32M | 227.06M | 251.61M |
| Research & development | 88.52M | 87.45M | 89.96M | 98.26M | 91.04M | 96.53M |
| Operating profit | -111.04M | -106.41M | -98.99M | -120.81M | -121.35M | -129.12M |
| Pretax profit | -94.87M | -99.86M | -92.59M | -130.22M | -111.70M | -119.96M |
| Tax | 290.00K | 38.00K | 136.00K | -1.73M | 372.00K | 185.00K |
| Net profit | -95.16M | -99.90M | -92.73M | -128.49M | -112.08M | -120.14M |
| Basic EPS | -1 | -1 | -1 | -1 | -1 | -1 |
| Diluted EPS | -0.77 | -0.80 | -0.74 | -1.00 | -0.85 | -0.90 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 468.99M | 597.36M | 1.89B | 1.11B | 1.19B | 1.35B | 1.06B | 1.47B |
| Cash & ST investments | 418.96M | 522.80M | 1.79B | 932.75M | 1.01B | 1.17B | 839.98M | 1.20B |
| Inventory | 9.14M | 15.18M | 22.72M | 30.67M | 51.60M | 61.95M | 71.08M | 85.88M |
| Total assets | 587.40M | 962.54M | 2.27B | 2.20B | 1.61B | 1.79B | 1.49B | 2.01B |
| Total current liabilities | 46.94M | 72.73M | 66.81M | 194.69M | 193.22M | 205.92M | 225.58M | 302.73M |
| Short-term debt | -- | 7.14M | 6.63M | 12.86M | 21.88M | 27.95M | 29.21M | 27.68M |
| Long-term debt | -- | -- | 806.29M | 1.13B | 1.14B | 1.14B | 1.14B | 1.50B |
| Total liabilities | 62,451,000.00 | 114,542,000.00 | 916,186,000.00 | 1,559,494,000.00 | 1,549,805,000.00 | 1,627,737,000.00 | 1,625,256,000.00 | 2,112,966,000.00 |
| Total equity | 524.95M | 847.99M | 1.36B | 645.01M | 60.18M | 158.68M | -139.65M | -99.31M |
| Retained earnings | -280.80M | -352.81M | -606.59M | -1.01B | -1.66B | -2.14B | -2.58B | -2.99B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 927.03M | 883.43M | 828.89M | 1.47B | 1.37B | 1.36B |
| Cash & ST investments | 698.57M | 629.14M | 580.01M | 1.20B | 1.10B | 1.05B |
| Inventory | 77.26M | 84.06M | 90.49M | 85.88M | 83.85M | 105.46M |
| Total assets | 1.34B | 1.33B | 1.28B | 2.01B | 1.92B | 1.91B |
| Total current liabilities | 225.75M | 238.43M | 236.92M | 302.73M | 292.15M | 338.96M |
| Short-term debt | 29.67M | 26.28M | 26.40M | 27.68M | 28.03M | 27.76M |
| Long-term debt | 1.12B | 1.12B | 1.11B | 1.50B | 1.50B | 1.50B |
| Total liabilities | 1,595,015,000.00 | 1,637,474,000.00 | 1,631,259,000.00 | 2,112,966,000.00 | 2,096,364,000.00 | 2,135,161,000.00 |
| Total equity | -250.79M | -305.48M | -354.47M | -99.31M | -181.07M | -222.87M |
| Retained earnings | -2.67B | -2.77B | -2.87B | -2.99B | -3.11B | -3.23B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -72.19M | -47.13M | -103.93M | -209.02M | -309.46M | -324.98M | -239.86M | -184.76M |
| Depreciation & amortization | 7.14M | 11.41M | 16.07M | 22.27M | 35.96M | 42.88M | 42.39M | 39.74M |
| Free cash flow | -92.39M | -68.42M | -157.99M | -284.05M | -386.92M | -345.46M | -274.94M | -233.07M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 253.83M | 350.43M | 355.73M | 0 | 0 | 493.12M | 0 | 299.99M |
| Ending cash balance | 140.54M | 143.23M | 832.98M | 492.29M | 141.95M | 1.13B | 629.76M | 489.42M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -62.69M | -60.29M | -35.41M | -26.37M | -65.62M | -57.78M |
| Depreciation & amortization | 10.24M | 10.04M | 9.41M | 10.05M | 9.44M | 9.56M |
| Free cash flow | -67.15M | -65.93M | -45.76M | -54.22M | -71.20M | -69.54M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -45.01M | 0 | 0 | 345.00M | 0 | 0 |
| Ending cash balance | 803.85M | 735.48M | 689.52M | 489.42M | 1.10B | 1.17B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -58.31 | -11.81 | -24.21 | -41.75 | -185.65 | -438.13 | -4,584.47 | -- |
| ROA %i | -18.29 | -9.76 | -15.69 | -18.13 | -34.32 | -28.23 | -26.67 | -23.79 |
| ROIC %i | -60.13 | -13.29 | -17.23 | -19.50 | -38.13 | -34.36 | -35.20 | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -64.34 | -140.31 | -1,054.84 | -- |
| EBIT margin %i | -91.54 | -31.97 | -84.10 | -102.21 | -144.79 | -84.44 | -58.52 | -42.12 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 9.99 | 8.21 | 28.27 | 5.72 | 6.17 | 6.54 | 4.68 | 4.84 |
| Quick ratioi | 9.68 | 7.85 | 27.66 | 5.29 | 5.74 | 6.11 | 4.21 | 4.42 |
| Debt / assetsi | 0.00 | 4.20 | 37.61 | 62.31 | 85.05 | 75.78 | 89.93 | 84.93 |
| LT debt / equityi | -- | 4.17 | 65.30 | 210.99 | 2,238.96 | 835.51 | -- | -- |
| Interest coveragei | -66.33 | -58.04 | -50.60 | -148.19 | -252.57 | -184.71 | -167.57 | -106.14 |
| Revenue CAGR (3Y) %i | -- | 104.01 | 79.18 | 60.34 | 28.00 | 25.29 | 25.52 | 29.75 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -27.33 | -28.14 | -28.33 | -23.79 | -26.58 | -27.95 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -53.31 | -49.43 | -43.68 | -42.12 | -39.80 | -38.01 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 4.11 | 3.71 | 3.50 | 4.84 | 4.68 | 4.03 |
| Quick ratioi | 3.61 | 3.18 | 2.94 | 4.42 | 4.25 | 3.53 |
| Debt / assetsi | 97.18 | 100.16 | 103.88 | 84.93 | 89.00 | 88.74 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -151.32 | -133.66 | -117.27 | -106.14 | -96.55 | -93.37 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 06:41:21 · For reference only, not investment advice and not tailored to your situation.